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Uterine sarcomas are rare tumors with poor prognosis and even
more rare in adolescents. They predominantly occur after the fourth de-
cade and represent less than 3% of all genital tractmalignancies (Seddon
and Davda, 2011). The symptoms of uterine sarcomas are almost iden-
tical to leiomyomas such as abnormal uterine bleeding (60%), abdomi-
nal pain (50%), and gastrointestinal or genitourinary symptoms (30%).
Uterine rupture and hemoperitoneum are rare presentations (Philip
et al., 2011).
The uterine sarcomas consist of pure mesenchymal tumors
(leiomyosarcoma (LMS), endometrial stromal sarcoma (ESS), undiffer-
entiated endometrial stromal sarcoma (UES)), andmixed epithelial and
mesenchymal tumors (adenosarcoma (AS) and adenosarcoma with
sarcomatoid overgrowth (ASSO)). Carsinosarcoma (CS) is reclassiﬁed
as the metaplastic form of endometrial cancer but the aggressiveness
resembles uterine sarcomas. STUMP is a smoothmuscle tumorwith un-
certain malignant potential (D'Angelo and Prat, 2010). Characteristic
pathologic features include highmitotic index, hypercellularity, nuclear
atypia, tumor cell necrosis, tumor size and intratumoral hemorrhage.
Pathologic diagnosis may be problematic because several variants
have confusing, subtle tumor characteristics and overlapping morpho-
logic features that make distinguishing among the entities challenging
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subsequent uterine rupture and hemoperitoneum in a 14 year old
African girl.Case
A 14 year old, thin, African female, gravida 0, was admitted to our
clinic with abdominal discomfort and increased abdominal circumfer-
ence. She had no subsequent menstrual abnormalities or previous
hormone use. Her past medical history was unremarkable and she had
no surgeries before. There was no family history of uterine myomas or
malignancy. Abdominal palpation showed a mobile, nontender mass
extending towards the umblicus. Pelvic ultrasonography revealed
solid heterogenous uterinemasses of 97 × 70mmand 46 × 43mmpro-
truding from left uterine wall. MRI showed the invasion of all uterine
layers. Tumor markers revealed normal, except CA 19-9 was 43.1 U/
ml. For deﬁnitive treatment, laparotomy with frozen section pathology
was planned. Exploration during laparotomy showed a 3 × 3 cm mass
on the posterior wall of the uterus. Another mass of 5 × 6 cm invaded
the endometrial cavity through the vagina with polipoid protrusions.
All lesions were excised. Frozen section pathology revealed
leiomyomata uteri with no malignant transformations and myomecto-
my alone was performed. She recovered uneventfully and was
discharged on the second postoperative day. The ﬁnal pathology report
revealed a benign leiomyomata uteri. The result seemed irrelevant with
the macroscopic appearance and we asked for a second opinion. The
consultation, as well, showed benign tumor with spindle cells suggest-
ing leiomyoma. Immunohistochemical staining was not performed
since there were no heterologous elements in the slides.
Eight months after the surgery, she, for the second time, attended to
our clinic with abdominal discomfort, fatigue, nausea and vomiting. She
looked pale and dyspneic. Abdominal palpation revealed a 20week ges-
tation sized, nonmobile, tendermass. Hb level was 9.3 g/dl. USG and ab-
dominal MRI revealed a 10 × 10 × 24 cm heterogenous mass with
predominantly solid components suggesting uterine sarcoma. CA -125
(2005.5 U/ml) and Ca 19-9 (92.6 U/ml) were elevated. She was hospi-
talized and during the preoperative diagnostic evaluation, the hemoglo-
bin levels started to decrease towards 7.1 g/dl. Reevaluation of the
patient revealed massive intraabdominal bleeding and she was
emergently referred for laparotomy. On gross examination during lapa-
rotomy, bulky nodular masses were scattered around the peritoneum,
intestines and the liver. These studded masses measured from 0.5 to
15 cm in diameter. Cut surfaces of solid masses appeared grayish
white and myxoid with cystic changes. The anatomic contours of thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 1. (A) Chondroid differentiation in tumoral tissue (hematoxylin and eosin, original
magniﬁcation × 40). (B) Mesenchymal tumor with crossing brunches of spindle cells
(hematoxylin and eosin, original magniﬁcation × 100).
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uterus distorted the adjacent structures. The left uterine artery was
ripped off and was ligated immediately. The supportive tissues of the
uterus, a 20 cm, irregular solid mass originating from the uterine wall
and the ovaries were excised through the presumed anatomic cleav-
ages. The scattered masses were all removed. She was discharged
from the hospital uneventfully two weeks later.
The pathology revealed “adenosarcoma with stromal overgrowth”, a
high grade sarcoma and she was referred to the oncology department
for chemotherapy.
Discussion
Thiswas anunusual case of an aggressively growinguterine sarcoma
occurring in a fourteen year old girl.
Sarcomas, occurring under the age of 20 are quite rare. Predisposing
factors are unclear but pelvic radiation therapy and tamoxifen, a selec-
tive estrogen receptor blocker is associated with high grade uterine sar-
comas (D'Angelo and Prat, 2010). Hormonal stimulus like pregnancy,
oral contraceptives or ovarian tumor may potentiate the mesothelium
and submesothelialmesenchyme to differentiate into sarcomas. Clinical
presentation is generally vaginal bleeding, pain, abdominal mass or se-
vere uremia due to pressure. In our case, the rapidly growing tumor
caused the rupture of the uterus and the patient was referred for emer-
gency laparotomy due to massive intraabdominal bleeding.
There are a few cases of sarcomas in the literature with devastating
presentations like uterine rupture and hypovolemic shock. De Roy and
Wiegerinck (1986), described a large rapidly growing tumor with
hemoperitoneum in a 15 year old girl. They concluded that the hemor-
rhagewas due to the ruptured vascular connection rather than the uter-
ine rupture and they preserved the uterus with the resection of the
tumor solely. A case of a uterine tumor at an older age, was reported
by Kim (2013), recently. The complaints, preoperative diagnostic fea-
tures and the intraoperative macroscopic appearance of the mass, re-
sembled those of our patient. The microscopic ﬁndings revealed
spindle cells and hemorrhagic necrosis but immunohystochemical
staining revealed rhabdomyosarcoma, atypical for that age. In another
case by Stadsvold et al. (2005), a low grade myxoid endometrial sarco-
ma in a nulliparous 16 year old girl wasmanaged by local resection and
uterine reconstruction. Another remarkable pointwith our casewas the
dissemination of the solid and cystic masses over the serosal surfaces.
There is a case report by Arneja (2011) about disseminated peritoneal
leiomyomatosis in an 18 year old girl. Benign dissemination was ex-
plained by the smooth muscle metaplasia of subperitoneal mesenchy-
mal stem cells of the secondary müllerian system. She was treated
with hysterectomy and bilateral salpingoopherectomy and showed
complete regression. In our case, it is probable that the pathology of
the initial surgery might have been misdiagnosed and if it was a sarco-
ma initially then the disseminationwas not due to themetaplasia of the
müllerian system but rather the dissemination of the malignant
cells during the ﬁrst operation. Another point of view implies that
morcellation of a uterine leiomyoma in a laparoscopic myomectomy
may rarely cause dissemination. In our case, the patient had amyomec-
tomy as a predisposing factor but it was an enucleation not a
morcellation of the mass. In most cases ﬁrm diagnosis can be problem-
atic. If a mass is noted in the uterine wall, the differential diagnosis will
include a benign leiomyoma versus a uterine sarcoma. Endometrial bi-
opsies are inadequate and often confounded by sampling error and
bias. The role of imaging in the assessment of uterine sarcoma has not
been well described given the rarity of the disease. Generally USG and
MRI are used for pretreatment assessment of local uterine spread. CT
is generally conﬁned to extrauterine spread and metastasis (Shah
et al., 2012). Tumor size, mitotic index, grade, age, race, tumor cell ne-
crosis, adnexial involvement, sarcomatous overgrowth, andmyometrial
invasion are the factors that inﬂuence the prognosis of sarcomas. Stan-
dard primary surgical treatment for uterine sarcomas includes totalhysterectomy with or without salpingoopherectomy considering fertil-
ity preservation. Surgical staging of pelvic and paraaortic nodes may be
helpful for carcinosarcoma and has less value for other uterine sarcoma
types. Aggressive tumor debulking may be valuable for extrauterine
spread. Chemotherapy may be beneﬁcial in advanced stage uterine sar-
comas. Although most uterine sarcomas are radiosensitive, the overall
survival does not change with radiotherapy. Hormonal therapy may
be useful for metastatic or recurrent sarcomas with estrogen and
progesteron receptors. We, in this case, planned TAH + BSO preopera-
tively but intraoperatively, the pelvic structureswere found to beunrec-
ognizable due to uterine rupture. We performed tumor debulking,
bilateral salpingoopherectomy and removed all solid and cystic masses
(Fig. 2). The specimens from the second surgery revealed necrosis,
atypia, sarcomatous components accompanied with myoid and
chondroid elements (Fig. 1A,B) and focal glandular components. The
major component of the tumor was the sarcomatous spindle cells and
immunohistochemical staining showed positive for vimentin and nega-
tive for SMA, eliminating leiomyosarcoma.
According toWHO classiﬁcation it was “adenosarcomawith stromal
overgrowth”; a subgroup of mixed epithelial andmesenchymal tumors.
The survival of our patient is unpredictable due to advanced stage
uterine sarcoma; she is still on her fourth chemotherapy line with
ifosfomide and etopaside.
Since a certain number of sarcomas will not be diagnosed until
after hysterectomy, the patient will be best managed by those
Fig. 2.Mesenchymal tumor of uterus and bulky masses.
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pathologists when a uterine sarcoma is suspected (Karlan et al., 2014).
Conclusion
Rapidly growing tumors may suggest uterine sarcomas which are
quite rare in adolescents. Uterine rupture or hypovolemic shock are in-
frequent presentations. Preoperative diagnosis may be controversial
since there are no clear criteria for malignancy. The experience of the
gynecologic surgeons and gynecopathologists constitutes the hallmark
of deﬁnitive diagnosis and treatment.
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